title: Methylenetetrahydrofolate reductase C677T polymorphism, venous thrombosis, cardiovascular risk, and other effects.
authors.affiliation: Gill Heart Institute, University of Kentucky, Lexington, KY, USA twhayn0@uky.edu.
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Whayne
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood; D015897:Comorbidity; D019587:Dietary Supplements; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006304:Health Status; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000188:drug therapy / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics*; D006973:Hypertension / Q000453:epidemiology; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D010641:Phenotype; D011110:Polymorphism, Genetic; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000097:blood / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics* / Q000517:prevention & control; D014803:Vitamin B Complex / Q000627:therapeutic use
chemical_list: D015415:Biomarkers; D006710:Homocysteine; D014803:Vitamin B Complex; C573423:MTHFR protein, human; D042965:Methylenetetrahydrofolate Reductase (NADPH2)